Client Login
Pay My Bill
Services
Adherence Monitoring
Pain Management
Mental Illness
Substance Use Disorder
Chronic Comorbidities
BioDetect
Novel Psychoactive Substances
InterACT Rx
Sports Testing
Clinical Blood Testing
Infectious Disease Testing
Clinical Resources
About Definitive Testing
Clinical Updates
Webinars
Events
Patient Impact Stories
Publications
Reference Guide
Collection Instructions
Work With Us
Current Openings
About
The Aegis Difference
Executive Leadership
Clinical and Scientific Team
Testimonials
Lab Tour
News
Contact
Client Login
Pay My Bill
Services
Adherence Monitoring
Pain Management
Mental Illness
Substance Use Disorder
Chronic Comorbidities
BioDetect
Novel Psychoactive Substances
InterACT Rx
Sports Testing
Clinical Blood Testing
Infectious Disease Testing
Clinical Resources
About Definitive Testing
Clinical Updates
Webinars
Events
Patient Impact Stories
Publications
Reference Guide
Collection Instructions
Work With Us
Current Openings
About
The Aegis Difference
Executive Leadership
Clinical and Scientific Team
Testimonials
Lab Tour
News
Contact
Client Login
Pay My Bill
News
Aegis Launches COVID-19 Testing Program for Schools
Additional Longer Term CDC Contract to Provide Genomic Sequencing of SARS-CoV-2
Aegis Sciences Corporation announces participation in National Testing Action Plan for K-12 Schools
Aegis Sciences Corporation Expands Novel Psychoactive Substance Testing
Aegis Sciences Announces Latest Innovation to Detect Patient Urine Substitution
Aegis Sciences Corporation and Walgreens announce expansion of COVID-19 diagnostic testing
4
5
6
7
8
9
10
Sign up for the Aegis Newsletter
Δ
Close